Pitfalls in analysis and interpretation of single-cell RNA-seq data in cancer

Single-cell and single-nuclei RNA-seq (sc/snRNA-seq) have become a central approach in cancer research, and their widespread impact has been enabled by various computational tools developed specifically for sc/snRNA-seq analysis. Nevertheless, proper analysis and interpretation of sc/snRNA-seq data requires significant expertise, and the inadequate utility of certain computational methods may lead to dubious results. To mitigate these issues, it is important to recognize the limitations of sc/snRNA-seq data, the assumptions of common methods, and to perform robust analysis. Here, I describe common pitfalls in cancer sc/snRNA-seq analysis and discuss ways to overcome them. Among others, this includes a discussion of potential errors in statistical analysis, in inference of chromosomal aberrations, in trajectory analysis, and in signature-based analysis of bulk RNA-seq data. This review may help readers to avoid common pitfalls and to perform informative analysis and careful interpretation of sc/snRNA-seq datasets in cancer.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology Advances
Published
2025-02-27
DOI
https://doi.org/10.1093/noajnl/vdaf047
Primary Topic
Single-cell and spatial transcriptomics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pitfalls in analysis and interpretation of single-cell RNA-seq data in cancer

Itay Tirosh
Neuro-Oncology Advances
Single-cell and spatial transcriptomics
article

Pitfalls in analysis and interpretation of single-cell RNA-seq data in cancer

Itay Tirosh
article en

Abstract

Single-cell and single-nuclei RNA-seq (sc/snRNA-seq) have become a central approach in cancer research, and their widespread impact has been enabled by various computational tools developed specifically for sc/snRNA-seq analysis. Nevertheless, proper analysis and interpretation of sc/snRNA-seq data requires significant expertise, and the inadequate utility of certain computational methods may lead to dubious results. To mitigate these issues, it is important to recognize the limitations of sc/snRNA-seq data, the assumptions of common methods, and to perform robust analysis. Here, I describe common pitfalls in cancer sc/snRNA-seq analysis and discuss ways to overcome them. Among others, this includes a discussion of potential errors in statistical analysis, in inference of chromosomal aberrations, in trajectory analysis, and in signature-based analysis of bulk RNA-seq data. This review may help readers to avoid common pitfalls and to perform informative analysis and careful interpretation of sc/snRNA-seq datasets in cancer.

Neuro-Oncology AdvancesVol. 8(Supplement_1)
American Committee for the Weizmann Institute of Science (US), Weizmann Institute of Science (IL)
Openalex Percentile: Top 33%
Single-cell and spatial transcriptomics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.